Cointime

Vical

company

About

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.

  • 251 - 500

Highlights

Total Funding Amount
$2.50M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$2.50M
Industries
Biotechnology,Genetics
Founded date
Jan 1, 1987
Number Of Employee
251 - 500
Operating Status
Active

Vical's core technology grew out of a chance discovery and provided the cornerstones for two new biopharmaceutical industry sectors: DNA vaccines and non-viral gene therapy.
Vical's management systematically leveraged that technology into a broad portfolio of independent and partnered product development programs. The first products for animal health are on the market. The first human products are approaching.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.50M
Vical has raised a total of $2.50M in funding over 2 rounds. Their latest funding was raised on Sep 29, 1988 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 29, 1988 Series Unknown $2.50M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Vical is funded by 2 investors. Sequoia Capital and Security Pacific Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital — Series Unknown
Security Pacific Capital — Series Unknown
Cointime
Содержание
компания